Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunities
Rolnick, Sharon J.
Yood, Robert A.
Weaver, W. Douglas
Von Worley, Ann
Hornbrook, Mark C.
Magid, David J.
Go, Alan S.
UMass Chan AffiliationsMeyers Primary Care Institute
Document TypeJournal Article
*Clinical Trials as Topic
Community Health Services
Health Services Research
MetadataShow full item record
AbstractBACKGROUND: The objective of our study was to examine cardiologists' and organizational leaders' interest in clinical trial participation and perceived barriers and facilitators to participation within ten diverse non-profit healthcare delivery systems. Trials play a pivotal role in advancing knowledge about the safety and efficacy of cardiovascular interventions and tests. Although cardiovascular trials successfully enroll patients, recruitment challenges persist. Community-based health systems could be an important source of participants and investigators, but little is known about community cardiologists' experiences with trials. METHODS: We interviewed 25 cardiology and administrative leaders and mailed questionnaires to all 280 cardiologists at 10 U.S. healthcare organizations. RESULTS: The survey received a 73% response rate. While 60% of respondents had not participated in any trials in the past year, nearly 75% wanted greater participation. Cardiologists reported positive attitudes toward trial participation; more than half agreed that trials were their first choice of therapy for patients, if available. Almost all leaders described their organizations as valuing research but not necessarily trials. Major barriers to participation were lack of physician time and insufficient skilled research nurses. CONCLUSIONS: Cardiologists have considerable interest in trial participation. Major obstacles to increased participation are lack of time and effective infrastructure to support trials. These results suggest that community-based health systems are a rich source for cardiovascular research but additional funding and infrastructure are needed to leverage this resource.
SourceContemp Clin Trials. 2008 Sep;29(5):646-53. Epub 2008 Mar 4. Link to article on publisher's site
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/37056
Related ResourcesLink to Article in PubMed